BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 30715139)

  • 21. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Are You Covered?
    Ha M; Ngaage LM; Zhu K; Hricz N; Slezak S; Rasko YM
    Aesthet Surg J; 2021 Nov; 41(12):NP1943-NP1949. PubMed ID: 33856438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of breast implant-associated anaplastic large cell lymphoma in patients submitted to breast implantation: A systematic review.
    Wohlgemuth FB; Brasil MBQ; d'Acampora AJ
    Breast J; 2019 Sep; 25(5):932-937. PubMed ID: 31155830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) for Breast Cancer Reconstruction: An Update for Surgical Oncologists.
    O'Neill AC; Zhong T; Hofer SOP
    Ann Surg Oncol; 2017 Oct; 24(11):3174-3179. PubMed ID: 28762113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BIA-ALCL in patients with genetic predisposition for breast cancer: our experience and a review of the literature.
    Carbonaro R; Accardo G; Mazzocconi L; Pileri S; Derenzini E; Veronesi P; Caldarella P; De Lorenzi F
    Eur J Cancer Prev; 2023 Jul; 32(4):370-376. PubMed ID: 37302016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
    Fleming D; Stone J; Tansley P
    Aesthetic Plast Surg; 2020 Aug; 44(4):1109-1115. PubMed ID: 32766915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological Profile in Portugal of Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Cross-Sectional Study.
    Cunha A; Horta R; Barreiro D
    Acta Med Port; 2021 Aug; 34(9):572-579. PubMed ID: 33512315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thirty-six (36) French cases of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): What do we know about their prosthetic histories, and what conclusions may be drawn?].
    Ruffenach L; Bruant-Rodier C; Goldammer F; Ramelli E; Bodin F; Dissaux C
    Ann Chir Plast Esthet; 2019 Aug; 64(4):285-292. PubMed ID: 31331683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights into the Microbiome of Breast Implants and Periprosthetic Tissue in Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Walker JN; Hanson BM; Pinkner CL; Simar SR; Pinkner JS; Parikh R; Clemens MW; Hultgren SJ; Myckatyn TM
    Sci Rep; 2019 Jul; 9(1):10393. PubMed ID: 31316085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and Treatment of Advanced Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Collins MS; Miranda RN; Medeiros LJ; Silva de Meneses MP; Iyer SP; Butler CE; Liu J; Clemens MW
    Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):41S-50S. PubMed ID: 30817555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Kadin ME; Deva A; Xu H; Morgan J; Khare P; MacLeod RA; Van Natta BW; Adams WP; Brody GS; Epstein AL
    Aesthet Surg J; 2016 Jul; 36(7):773-81. PubMed ID: 26979456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BIA-ALCL and Textured Breast Implants: A Systematic Review of Evidence Supporting Surgical Risk Management Strategies.
    Nelson JA; McCarthy C; Dabic S; Polanco T; Chilov M; Mehrara BJ; Disa JJ
    Plast Reconstr Surg; 2021 May; 147(5S):7S-13S. PubMed ID: 33890875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Prospective Approach to Inform and Treat 1340 Patients at Risk for BIA-ALCL.
    Roberts JM; Carr LW; Jones A; Schilling A; Mackay DR; Potochny JD
    Plast Reconstr Surg; 2019 Jul; 144(1):46-54. PubMed ID: 31246798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Defining Future Research Priorities.
    DeCoster RC; Lynch EB; Bonaroti AR; Miranda RN; Hunt KK; Clemens MW
    Clin Plast Surg; 2021 Jan; 48(1):33-43. PubMed ID: 33220903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Crucial Role of Surgical Treatment in BIA-ALCL Prognosis in Early- and Advanced-Stage Patients.
    Campanale A; Spagnoli A; Lispi L; Boldrini R; Marletta M
    Plast Reconstr Surg; 2020 Nov; 146(5):530e-538e. PubMed ID: 32852469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Public Perceptions on Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Lee E; Khavanin N; He W; Darrach H; Kraenzlin F; Jenny H; Yang R; Sacks JM
    Plast Reconstr Surg; 2020 Jul; 146(1):30-37. PubMed ID: 32590638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is Banning Texturized Implants to Prevent Breast Implant-Associated Anaplastic Large Cell Lymphoma a Rational Decision? A Meta-Analysis and Cost-Effectiveness Study.
    Danilla SV; Jara RP; Miranda F; Bencina F; Aguirre M; Troncoso E; Erazo CA; Andrades PR; Sepulveda SL; Albornoz CR
    Aesthet Surg J; 2020 Jun; 40(7):721-731. PubMed ID: 31761953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.
    Kadin ME; Morgan J; Xu H; Epstein AL; Sieber D; Hubbard BA; Adams WP; Bacchi CE; Goes JCS; Clemens MW; Medeiros LJ; Miranda RN
    Hum Pathol; 2018 Aug; 78():54-62. PubMed ID: 29689246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. European Attitudes and Outcomes Regarding Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Multinational Survey.
    Villarroya-Marquina I; Moshrefi S; Sheckter C; Lee GK
    Aesthetic Plast Surg; 2020 Oct; 44(5):1387-1395. PubMed ID: 32367324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast Implant-Associated Anaplastic Large-Cell Lymphoma in Brazil: What Are We Missing?
    Groth AK; Clemens MW; Graf R; SebastiĆ£o AP; Azambuja AP; Louveira MH; Urban LABD; Batista BN
    Plast Reconstr Surg; 2022 Nov; 150(5):970e-978e. PubMed ID: 35994334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Hanson SE; Hassid VJ; Branch-Brooks C; Liu J; Kadin ME; Miranda R; Butler CE; Clemens MW
    Aesthet Surg J; 2020 Jan; 40(2):149-153. PubMed ID: 30789639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.